Amgen, Inc. (AMGN) EPS Estimated At $3.09, Myers Industries (MYE) Sellers Decreased By 1.42% Their Shorts

June 27, 2017 - By Stephen Andrade

Myers Industries Incorporated (NYSE:MYE) had a decrease of 1.42% in short interest. MYE’s SI was 373,600 shares in June as released by FINRA. Its down 1.42% from 379,000 shares previously. With 70,400 avg volume, 5 days are for Myers Industries Incorporated (NYSE:MYE)’s short sellers to cover MYE’s short positions. The SI to Myers Industries Incorporated’s float is 1.32%. It closed at $18.3 lastly. It is down 22.42% since June 27, 2016 and is uptrending. It has outperformed by 5.72% the S&P500.

Analysts expect Amgen, Inc. (NASDAQ:AMGN) to report $3.09 EPS on July, 26.They anticipate $0.25 EPS change or 8.80% from last quarter’s $2.84 EPS. AMGN’s profit would be $2.29 billion giving it 14.05 P/E if the $3.09 EPS is correct. After having $3.15 EPS previously, Amgen, Inc.’s analysts see -1.90% EPS growth. It closed at $173.67 lastly. It is down 5.27% since June 27, 2016 and is uptrending. It has underperformed by 11.43% the S&P500.

Investors sentiment increased to 2 in Q4 2016. Its up 0.68, from 1.32 in 2016Q3. It is positive, as 5 investors sold Myers Industries, Inc. shares while 23 reduced holdings. 13 funds opened positions while 43 raised stakes. 24.56 million shares or 0.45% less from 24.67 million shares in 2016Q3 were reported. Moors & Cabot owns 48,751 shares or 0.12% of their US portfolio. Secor Capital Advisors L P invested in 0.08% or 43,839 shares. 109,769 are held by Ameriprise Financial. Arizona State Retirement holds 11,286 shares. Renaissance Techs Limited holds 0% or 114,100 shares in its portfolio. Citadel Advisors Ltd Llc stated it has 0% in Myers Industries, Inc. (NYSE:MYE). Jpmorgan Chase accumulated 193,514 shares. Gamco Invsts Et Al reported 5.05M shares. Janus Cap Mngmt Ltd Liability holds 0% of its portfolio in Myers Industries, Inc. (NYSE:MYE) for 83,788 shares. Teachers Retirement Of The State Of Kentucky reported 4,690 shares stake. D E Shaw & invested in 30,058 shares or 0% of the stock. Nationwide Fund Advsr reported 15,825 shares or 0% of all its holdings. State Of Alaska Department Of Revenue has invested 0% in Myers Industries, Inc. (NYSE:MYE). Blackrock Management Ltd, New Jersey-based fund reported 116,532 shares. Public Employees Retirement Association Of Colorado owns 12,082 shares for 0% of their portfolio.

Since March 21, 2017, it had 1 insider purchase, and 4 insider sales for $39,708 activity. GAMCO INVESTORS – INC. ET AL had sold 400 shares worth $6,755. SCACCETTI JANE had bought 3,000 shares worth $51,600 on Monday, May 15.

Myers Industries, Inc. is an international manufacturing and distribution company. The company has market cap of $556.53 million. The Firm operates through two divisions: Material Handling and Distribution. It has a 69.15 P/E ratio. As of December 31, 2016, the Company operated 15 manufacturing facilities, 20 sales offices, four distribution centers and three distribution branches located throughout North, Central and South America.

Among 19 analysts covering Amgen Inc. (NASDAQ:AMGN), 9 have Buy rating, 0 Sell and 10 Hold. Therefore 47% are positive. Amgen Inc. had 35 analyst reports since August 3, 2015 according to SRatingsIntel. Atlantic Securities initiated Amgen, Inc. (NASDAQ:AMGN) rating on Friday, December 18. Atlantic Securities has “Overweight” rating and $202 target. Piper Jaffray maintained Amgen, Inc. (NASDAQ:AMGN) rating on Saturday, August 29. Piper Jaffray has “Overweight” rating and $200 target. The stock of Amgen, Inc. (NASDAQ:AMGN) earned “Market Perform” rating by Bernstein on Wednesday, June 29. UBS maintained it with “Buy” rating and $180 target in Thursday, October 29 report. The stock of Amgen, Inc. (NASDAQ:AMGN) has “Hold” rating given on Friday, August 26 by Gabelli. Leerink Swann initiated the shares of AMGN in report on Friday, February 5 with “Market Perform” rating. The stock of Amgen, Inc. (NASDAQ:AMGN) has “Neutral” rating given on Wednesday, September 28 by Citigroup. The rating was maintained by Oppenheimer on Monday, June 5 with “Buy”. The stock has “Outperform” rating by Oppenheimer on Tuesday, December 13. The stock of Amgen, Inc. (NASDAQ:AMGN) has “Buy” rating given on Monday, September 7 by UBS.

Since May 24, 2017, it had 0 insider buys, and 2 sales for $1.02 million activity. BALTIMORE DAVID sold $569,541 worth of stock or 3,700 shares. 2,922 Amgen, Inc. (NASDAQ:AMGN) shares with value of $451,164 were sold by Patton Cynthia M.